GASCID Chewable Tablets (Aluminium Hydroxide + Magnesium Trisilicate + Simethicone)

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Bahan aktif:

DRIED ALUMINIUM HYDROXIDE; Magnesium Trisilicate; Simethicone

Boleh didapati daripada:

HEALOL PHARMACEUTICALS SDN. BHD.

INN (Nama Antarabangsa):

DRIED ALUMINIUM HYDROXIDE; Magnesium Trisilicate; Simethicone

Unit dalam pakej:

10 X 10 Tablets

Dikeluarkan oleh:

XL Laboratories Pvt. Ltd.

Risalah maklumat

GASCID CHEWABLE TABLETS
_Consumer Medication Information Leaflet (RiMUP)_
Aluminium Hydroxide 250mg + Magnesium Trisilicate 250mg + Simethicone
25mg
1
WHAT IS IN THIS LEAFLET
1.
What
_GASCID_
is used for
2.
How
_GASCID _
works
3.
Before you use
_GASCID_
_4._
_ _
How to use
_GASCID _
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of
_GASCID_
8.
Product Description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
11.
Serial number
WHAT IS _GASCID_ USED FOR
_GASCID_
contains Dried Aluminium
Hydroxide, Magnesium Trisilicate
and Simethicone. It is used for the
symptomatic relief of dyspepsia,
heartburn and flatulence.
HOW _GASCID_ WORKS
Aluminium hydroxide and
magnesium trisilicate, an antacid,
neutralize or buffer existing
quantities of stomach acid, thus
providing relief of symptoms of
excess acid. Simethicone, an anti-
flatulent, relieves by belching or
passing flatus.
BEFORE YOU USE _GASCID _
-
_When you must not use it _
•
If you are hypersensitivity to the
ingredients of this product.
•
If you are having severe
debilitated.
•
If you are suffering from kidney
failure.
•
If you are having rare hereditary
problems of fructose intolerance,
glucose-galactose malabsorption
or sucrase-isomaltase
insufficiency.
Do not use this medicine if any of the
above applies to you. If you are not
sure, talk to your doctor or
pharmacist before using
_GASCID_
.
_Pregnancy and breast-feeding _
_GASCID_
should only be used after
consulting your doctor or pharmacist.
-
_Before you start to use it _
Please make sure you have
understood the explanation given by
your doctor or pharmacist before
taking this medicine.
-
_Taking other medications _
Please tell you doctor or pharmacist
if you are taking or have recently
taken any other medicines. This
includes medicines that you buy
without a prescription, herbal
medicines, dietary supplements or
vitamins. This is especially important
if you take one of the following
medicines:
•
tetracyclines
•
vitamins
•
ciprofloxacin
•
ketoconazole
•

Ciri produk

Size : 165x120 mm
COMPOSITION:
Each uncoated chewable tablet contains:
Dried Aluminium Hydroxide BP 250 mg
Magnesium Trisilicate BP 250 mg
Simeticone BP 25 mg
DESCRIPTION: Pink, coloured, round, flat, uncoated chewable tablets,
debossed with “GASCID” on one side and plain on other side.
PHARMACOLOGY:
Dried aluminium hydroxide gel - antacid
Magnesium Trisilicate - antacid
Simeticone - Antifoaming agent/antiflatulent
The
antacids
are
balanced
such
that
gastrointestinal
side
effects
(constipation and diarrhoea) are minimal.
PHARMACOKINETICS:
NONE- STATED
INDICATION:
The symptomatic relief of Dyspepsia, Heartburn & Flatulence.
DOSAGE AND ADMINISTRATION:
Adults (including elderly persons): 1-2 tablets well chewed, four
times a
day.
To be taken 20 minutes to 1 hour after meals and at bedtime, or as
required.
CHILDREN: Not recommended
CONTRAINDICATION:
Should not be used in patients who are severely debilitated or
suffering
from kidney failure.
Patients with rare hereditary problems of fructose intolerance,
glucose-
galactose malabsorption or sucrase-isomaltase insufficiency should not
take this medicine.
Hypersensitivity to the active ingredients or to any of the
excipients.
PRECAUTIONS:
Aluminium hydroxide may cause constipation and magnesium salts
overdose may cause hypomotility of the bowel; large doses of this
product
may trigger or aggravate intestinal obstruction and ileus in patients
at
higher risk such as those with renal impairment, or the elderly.
Aluminium hydroxide is not well absorbed from the gastrointestinal
tract,
and systemic effects are therefore rare in patients with normal renal
function. However, excessive doses or long-term use, or even normal
doses in patients with low-phosphorus diets, may lead to phosphate
depletion
(due
to
aluminium-phosphate
binding)
accompanied
by
increased
bone
resorption
and
hypercalciuria
with
the
risk
of
osteomalacia. Medical advice is recommended in case of long-term use
or
in patients at risk of phosphate depletion.
In patients with renal impairment, plasma levels